[Federal Register Volume 90, Number 222 (Thursday, November 20, 2025)]
[Notices]
[Pages 52412-52413]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-20394]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-0361.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Program Evaluation for Prevention Contract (PEPC)
Evaluation (OMB No. 0930-0377)--Revision
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to complete
a cross-site evaluation of SAMHSA's SPF Rx grant program. SPF Rx is
designed to address nonmedical use of prescription drugs as well as
opioid overdoses by raising awareness about the dangers of sharing
medications and by working with pharmaceutical and medical communities
on the risks of overprescribing. The SPF Rx program grantees also raise
community awareness and bring activities related to prescription drug
misuse prevention and education to schools, communities, parents,
prescribers, and their patients. The SPF Rx program aims to promote
collaboration between states, tribes, U.S. territories, and
pharmaceutical and medical communities to understand the risks of
overprescribing to youth ages 12-17 and adults 18 years of age and
older. The program also aims to enhance capacity for, and access to,
Prescription Drug Monitoring Program (PDMP) data for prevention
purposes.
This request for data collection includes a revision to previously
approved Office of Management and Budget (OMB) instruments to allow for
data collection through the end of the grant period with the FY 2021
and FY 2022 grantees. The FY 2021 cohort of grants focuses on the
dangers of sharing medications; the risks of overprescribing,
especially to young adults; community awareness and education; and
incorporation of PDMP data into grantees' needs assessments and
strategic plans. The FY 2022 cohort of grants focused on raising
awareness about the risks of sharing medications, taking fake or
counterfeit pills, and overprescribing.
The SPF Rx program's indicators of success are reductions in opioid
overdoses, reduction in prescription drug misuse and improved use of
PDMP data. Data collected through the tools described in this statement
will be used for the national cross-site evaluation of SAMHSA's SPF Rx
program. The Program Evaluation for Prevention Control (PEPC) team will
systematically collect and maintain an Annual Reporting Tool (ART) and
Grantee and Community Level Outcomes data modules submitted by SPF Rx
grantees through the online Data Management System (DMS), and conduct
telephone interviews with SPF Rx grantees.
SAMHSA is requesting approval for data collection for the SPF Rx
cross-site evaluation with the following instruments:
Annual Reporting Tool (ART)--The ART is a survey instrument
collected yearly to monitor state, territory, tribal entity, and
community-level performance, and to evaluate the
[[Page 52413]]
effectiveness of the SPF Rx program. This tool is completed by grantees
and sub-recipient community project directors and provides process data
related to funding use and effectiveness, organizational capacity,
collaboration with community partners, data infrastructure, planned
intervention targets, evaluation, contextual factors, and
sustainability.
Grantee-and Community-Level Outcomes Modules--These modules collect
data on key SPF Rx program outcomes, including opioid prescribing
patterns and provider use of PDMP. Grantees will provide outcomes data
at the grantee level for their state, tribal area, or jurisdiction, as
well as at the community level for each of their sub-recipient
communities.
Grantee-Level Interview--This qualitative interview will be
administered annually to obtain information from the grantee project
directors on their programs, staffing, populations of focus,
infrastructure, capacity, lessons learned, and collaboration.
Average Annualized Data Collection Burden for the PEPC Data Collection \a\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Annualized
Average Average number Average Hours per Average Hourly wage data
Instrument number of of responses number of response burden \c d\ collection
respondents per respondent responses hours burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
ART....................................................... \b\ 107 1 107 1.5 161 $30.56 $4,920.16
\c\ 21 1 21 1.5 31 50.85 1,576.35
---------------------------------------------------------------------------------------------
Total Burden for ART.................................. 128 .............. 128 ........... 192 ........... 6,496.51
Grantee-Level PDMP Outcomes Module........................ \c\ 21 1 21 2.5 52 50.85 2,627.25
Community-Level PDMP Outcomes Module...................... \c\ 21 5.2 107 1.25 134.17 50.85 6,822.38
Grantee-Level Interview................................... \c\ 21 1 21 1.5 31 50.85 1,576.35
---------------------------------------------------------------------------------------------
Total Annualized Burden............................... 191 .............. 277 ........... 409.17 ........... 17,522.49
--------------------------------------------------------------------------------------------------------------------------------------------------------
\a\ Annualized Data Collection Burden captures the average number of respondents and responses, burden hours, and respondent cost over the 3 years (FY
2026-FY 2028).
\b\ Community subrecipient respondent.
\c\ Grantee respondent.
\d\ Grantee Project Director or Evaluator hourly wage is based on the mean hourly wage for state government managers, as reported in the 2023
Occupational Employment (OES) by the Bureau of Labor Statistics (BLS) found at https://www.bls.gov/oes/current/naics4_999200.htm#11-00000.
\e\ Subrecipient Staff hourly wage is based on the mean hourly wage for local government counselors, social workers, and other community and social
service specialists, as reported in the 2023 OES by the BLS found at https://www.bls.gov/oes/current/naics4_999300.htm.
Send comments to SAMHSA Reports Clearance Officer, 5600 Fishers
Lane, Room 15E57-A, Rockville, Maryland 20857, OR email a copy to
[email protected]. Written comments should be received by
January 20, 2026.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2025-20394 Filed 11-19-25; 8:45 am]
BILLING CODE 4162-20-P